Serotonin-producing neuroendocrine tumor of pancreas

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:506090E16.8C25.4
Who is this for?
Show terms as
2FDA treatments2Active trials1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

A serotonin-producing neuroendocrine tumor of the pancreas (also called a pancreatic serotonin-secreting NET, or pancreatic carcinoid tumor) is a rare type of tumor that grows in the pancreas. Unlike most pancreatic cancers, this tumor is made up of specialized cells called neuroendocrine cells, which normally help control digestion and hormone release. What makes this tumor unusual is that it releases large amounts of serotonin — a chemical messenger — directly into the bloodstream. This can cause a wide range of symptoms throughout the body. Because serotonin affects many organs, people with this tumor often experience flushing of the skin, diarrhea, stomach cramps, and wheezing. Over time, the excess serotonin can damage the heart valves, a condition called carcinoid heart disease. The tumor may also grow slowly and spread to the liver or other organs before it is discovered, since early symptoms can be easy to miss or mistake for other conditions. Treatment depends on how far the tumor has spread. Surgery to remove the tumor is the main goal when possible. Medications called somatostatin analogs (such as octreotide and lanreotide) can help control symptoms and slow tumor growth. Newer targeted therapies like everolimus and sunitinib, as well as a radioactive treatment called PRRT (peptide receptor radionuclide therapy), are also available. With the right care, many people live for years after diagnosis.

Also known as:

Key symptoms:

Sudden redness or flushing of the face and neckFrequent watery diarrheaStomach cramping or painWheezing or shortness of breathRapid or irregular heartbeatFatigue and low energyWeight loss without tryingSwelling in the legs or anklesNausea or vomitingLow blood sugar episodes (dizziness, shakiness, sweating)

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Sep 2024A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

TrialRECRUITING
Apr 2023Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

University of California, San Francisco

TrialRECRUITING
May 2022Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms

Fudan University — PHASE2

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

NETSPOT

Gallium [Ga-68]-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide· Advanced Accelerator Applications, USA

indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs)

Detectnet

copper Cu 64 dotatate· RadioMedix Inc.

indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients

Clinical Trials

2 recruitingView all trials with filters →
Other2 trials
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Actively Recruiting
PI: Emily Bergsland, MD (University of California, San Francisco) · Sites: Los Angeles, California; San Diego, California +1 more · Age: 1899 yrs
A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Actively Recruiting
PI: Jiuliang Yan, M.D. (Shanghai General Hospital, Shanghai Jiao Tong Univ) · Sites: Shanghai, Shanghai Municipality · Age: 1880 yrs

Specialists

1 foundView all specialists →
JC
Jennifer A Chan
Specialist
PI on 1 active trial103 Serotonin-producing neuroendocrine tumor of pancreas publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Serotonin-producing neuroendocrine tumor of pancreas.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Serotonin-producing neuroendocrine tumor of pancreasForum →

No community posts yet. Be the first to share your experience with Serotonin-producing neuroendocrine tumor of pancreas.

Start the conversation →

Latest news about Serotonin-producing neuroendocrine tumor of pancreas

No recent news articles for Serotonin-producing neuroendocrine tumor of pancreas.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has my tumor spread, and if so, where has it gone?,Is surgery an option for me, and what are the risks?,Should I start a somatostatin analog injection, and how often will I need it?,Do I need to be tested for an inherited syndrome like MEN1 or von Hippel-Lindau?,How will you monitor my heart for carcinoid heart disease?,Am I a candidate for PRRT (Lutathera) treatment?,Are there any clinical trials I should consider?

Common questions about Serotonin-producing neuroendocrine tumor of pancreas

What is Serotonin-producing neuroendocrine tumor of pancreas?

A serotonin-producing neuroendocrine tumor of the pancreas (also called a pancreatic serotonin-secreting NET, or pancreatic carcinoid tumor) is a rare type of tumor that grows in the pancreas. Unlike most pancreatic cancers, this tumor is made up of specialized cells called neuroendocrine cells, which normally help control digestion and hormone release. What makes this tumor unusual is that it releases large amounts of serotonin — a chemical messenger — directly into the bloodstream. This can cause a wide range of symptoms throughout the body. Because serotonin affects many organs, people wit

How is Serotonin-producing neuroendocrine tumor of pancreas inherited?

Serotonin-producing neuroendocrine tumor of pancreas follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Serotonin-producing neuroendocrine tumor of pancreas typically begin?

Typical onset of Serotonin-producing neuroendocrine tumor of pancreas is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Serotonin-producing neuroendocrine tumor of pancreas?

Yes — 2 recruiting clinical trials are currently listed for Serotonin-producing neuroendocrine tumor of pancreas on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Serotonin-producing neuroendocrine tumor of pancreas?

1 specialists and care centers treating Serotonin-producing neuroendocrine tumor of pancreas are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.